Biophytis secures Brazilian funding and partnerships for obesity Phase 2 trial

Phrontline Biopharma doses first patient in TJ101 Phase 1 clinical trial

Gene Solutions' mitochondrial therapy platform targeting neurological diseases secures patent

Zhimeng Biopharma's investigational drug gains Phase 2 epilepsy clinical trial approval in China

Avidity Biosciences prices upsized common stock public offering

EMA validates Daiichi Sankyo's ENHERTU type II variation application for HER2 positive metastatic solid tumours

Sanofi's SAR402663 granted FDA fast track designation for wet AMD

Endo to share PFI and PFA data at American Orthopaedic Foot & Ankle Society Annual Meeting

Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes

Sanofi secures China approval for Tzield as first disease-modifying therapy for stage 2 type 1 diabetes

Sobi's Biologics License Application for NASP in uncontrolled gout accepted by FDA

Hydrosome Labs announces promising fermentation breakthrough with ultrafine bubbles

Ionis receives FDA Breakthrough Therapy designation for ION582 in Angelman syndrome

AMO Pharma signs licence agreement with PHRI and Venca Research Inc to advance new study in ARVC

Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD